Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

HCA Healthcare Inc (HCA.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-25260.08289.00Buy
2022-04-25210.50241.00Buy
2022-06-27179.82207.00Buy
2022-07-25198.63227.00Buy
2022-10-24210.36237.00Buy
2022-12-21242.90-No Rating
2023-01-12255.15296.00Buy
2023-05-19282.47325.00Buy
2023-07-28273.25323.00Buy
2023-10-25225.36305.00Buy
2024-01-30301.59348.00Buy
2024-04-29311.42363.00Buy
2024-05-20325.05377.00Buy
2024-07-23340.17405.00Buy
2024-08-14371.58438.00Buy

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.